Article
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors.
Antimicrobial agents and chemotherapy - 1 Aug 1993
Byrnes V W, Sardana V V, Schleif W A, Condra J H, Waterbury J A, Wolfgang J A, Long W J, Schneider C L, Schlabach A J, Wolanski B S
Abstract excerpt
The nonnucleoside reverse transcriptase (RT) inhibitors comprise a class of structurally diverse compounds that are functionally related and specific for the human immunodeficiency virus type 1 RT. Viral variants resistant to these compounds arise readily in cell culture and in treated, infected...
Topics
- Acquired Immunodeficiency Syndrome
- Antiviral Agents
- Benzoxazoles
- DNA, Viral
- Genetic Variation
- HIV Reverse Transcriptase
- HIV-1
- Humans
- Mutation
- Nucleosides
- Pyridones
